Methylation of histone H3 Lys4 (H3K4), which is predominantly associated with actively transcribed genes [1] [2] [3] , is mainly mediated by MLL family histone lysine methyltransferases (HKMTs). Mammalian MLL family HKMTs contain six members (MLL1-MLL4, SET1A and SET1B) [2] [3] [4] , each of which has crucial yet non-redundant roles in cells [4] [5] [6] . MLL1 has been the most intensively studied because of its involvement by chromosomal translocations in a variety of acute lymphoid and myeloid leukaemias 6, 7 . Recently, inactivating mutations in MLL3 (also known as KMT2C) and MLL4 (KMT2D) have been identified in several types of human tumours and in Kabuki syndrome [8] [9] [10] [11] [12] . In contrast to most SET [SU(VAR)3-9, E(Z) and TRX]-domaincontaining methyltransferases, MLL1 protein alone exhibits poor HKMT activity 13, 14 . The crystal structure of the MLL1 SET domain (MLL1 SET ) reveals an open conformation that is not efficient for the methyl transfer from the cofactor S-adenosyl-l-methionine (AdoMet) to the target lysine 15 . The optimal HKMT activity of MLL1 requires additional factors, WDR5, RBBP5 and ASH2L, which are shared core components of all MLL complexes and also evolutionarily conserved from yeast to humans 13, 16 . Depletion of any of these components results in the global loss of H3K4 methylation to varying degrees [16] [17] [18] . Despite the importance of WDR5, RBBP5 and ASH2L, it is still unclear how these factors stimulate the HKMT activity of MLL proteins. In this work, our biochemical and structural analyses reveal how RBBP5-ASH2L binds and activates MLL family methyltransferases through a conserved mechanism.
Methylation of histone H3 Lys4 (H3K4), which is predominantly associated with actively transcribed genes [1] [2] [3] , is mainly mediated by MLL family histone lysine methyltransferases (HKMTs). Mammalian MLL family HKMTs contain six members (MLL1-MLL4, SET1A and SET1B) [2] [3] [4] , each of which has crucial yet non-redundant roles in cells [4] [5] [6] . MLL1 has been the most intensively studied because of its involvement by chromosomal translocations in a variety of acute lymphoid and myeloid leukaemias 6, 7 . Recently, inactivating mutations in MLL3 (also known as KMT2C) and MLL4 (KMT2D) have been identified in several types of human tumours and in Kabuki syndrome [8] [9] [10] [11] [12] .
In contrast to most SET [SU(VAR)3-9, E(Z) and TRX]-domaincontaining methyltransferases, MLL1 protein alone exhibits poor HKMT activity 13, 14 . The crystal structure of the MLL1 SET domain (MLL1 SET ) reveals an open conformation that is not efficient for the methyl transfer from the cofactor S-adenosyl-l-methionine (AdoMet) to the target lysine 15 . The optimal HKMT activity of MLL1 requires additional factors, WDR5, RBBP5 and ASH2L, which are shared core components of all MLL complexes and also evolutionarily conserved from yeast to humans 13, 16 . Depletion of any of these components results in the global loss of H3K4 methylation to varying degrees [16] [17] [18] . Despite the importance of WDR5, RBBP5 and ASH2L, it is still unclear how these factors stimulate the HKMT activity of MLL proteins. In this work, our biochemical and structural analyses reveal how RBBP5-ASH2L binds and activates MLL family methyltransferases through a conserved mechanism.
RBBP5-ASH2L binds and activates MLLs
We first examined the effects of individual components (WDR5, RBBP5 and ASH2L) and their combinations on the HKMT activities of MLL family methyltransferases. We selected the carboxyterminal conserved regions of MLL proteins containing both the WIN (WDR5-interaction) motif and the SET domain in activity assays 14 ( Fig. 1a) . For simplicity, hereafter we use 'MLL' to represent the MLL WIN-SET fragment, and 'MLL SET ' to represent the MLL SET domain unless stated otherwise. Consistent with previous observations 14, 15, 19 , activity assays showed that the RBBP5-ASH2L heterodimer substantially upregulated the HKMT activity of MLL1, and this activity was further stimulated by the addition of WDR5 (Fig. 1b and Extended Data Fig. 1a-c) . By contrast, MLL2-MLL4, SET1A and SET1B can be fully activated by just RBBP5-ASH2L, and WDR5 was dispensable for activity regulation (Fig. 1b and Extended Data Fig. 1a-c) . The stimulatory effect of RBBP5-ASH2L on MLL HKMT activities indicated a possible direct interaction between RBBP5-ASH2L and MLL proteins [20] [21] [22] . Indeed, a glutathione S-transferase (GST) pull-down assay clearly showed that all MLL proteins directly interact with RBBP5-ASH2L ( Fig. 1c and Extended Data Fig. 2a ). Among them, MLL2-MLL4 could be efficiently pulled down by GST-ASH2L-RBBP5, whereas SET1A and SET1B maintained a medium level of interaction with RBBP5-ASH2L ( Fig. 1c and Extended Data Fig. 2a) . By contrast, MLL1 only exhibited a very weak interaction with RBBP5-ASH2L under low-salt buffer conditions (Fig. 1c and Extended Data Fig. 2a) . Fluorescence polarization analysis also revealed that MLL proteins interact with RBBP5-ASH2L with very different binding affinities ranging from ~100 nM (for MLL3) to more than 100 μM (for MLL1) (Extended Data Fig. 2b) . Formation of the RBBP5-ASH2L heterodimer is a prerequisite for MLL binding, as neither RBBP5 nor ASH2L alone can stably associate with MLL proteins (Extended Data Fig. 2c, d) . Notably, MLL proteins can also stabilize the RBBP5-ASH2L interaction when high-salt buffer was used in the pull-down assay (Extended Data Fig. 2a) , consistent with the observation that the RBBP5-ASH2L interaction is highly sensitive to ionic strength (Extended Data  Fig. 2e ).
The mixed lineage leukaemia (MLL) family of proteins (including MLL1-MLL4, SET1A and SET1B) specifically methylate histone 3 Lys4, and have pivotal roles in the transcriptional regulation of genes involved in haematopoiesis and development. The methyltransferase activity of MLL1, by itself severely compromised, is stimulated by the three conserved factors WDR5, RBBP5 and ASH2L, which are shared by all MLL family complexes. However, the molecular mechanism of how these factors regulate the activity of MLL proteins still remains poorly understood. Here we show that a minimized human RBBP5-ASH2L heterodimer is the structural unit that interacts with and activates all MLL family histone methyltransferases. Our structural, biochemical and computational analyses reveal a two-step activation mechanism of MLL family proteins. These findings provide unprecedented insights into the common theme and functional plasticity in complex assembly and activity regulation of MLL family methyltransferases, and also suggest a universal regulation mechanism for most histone methyltransferases.
Article reSeArcH
Because MLL1 only maintained a weak direct interaction with RBBP5-ASH2L, we proposed that full activation of MLL1 by RBBP5-ASH2L requires the bridging molecule WDR5 that can interact with both MLL1 and RBBP5-ASH2L simultaneously. Consistent with this idea, the stimulatory effect of WDR5 on MLL1 HKMT activity is minimized when the protein concentration was increased in the assay (Extended Data Fig. 2f) . Furthermore, the fusion of RBBP5 and MLL1 together achieved a robust HKMT activity that cannot be further stimulated by the addition of WDR5 (Extended Data Fig. 2g ), suggesting that WDR5 per se is not directly involved in the MLL HKMT enzymatic reaction. Collectively, we conclude that RBBP5-ASH2L is the major functional unit that binds and activates MLL proteins. Conversely, WDR5 may have an indirect role in promoting HKMT activity by acting as a bridging molecule to facilitate the formation of MLL complexes under certain assay conditions, and this may explain the apparent discrepancy in reports about the role of WDR5 in the activity regulation of MLL complexes [19] [20] [21] [22] .
Complex structure of MLL3-RBBP5-ASH2L
To determine the structural basis of how RBBP5-ASH2L activates MLL proteins, we first dissected the interactions among RBBP5, ASH2L and the SET domains of MLL proteins. Consistent with previous studies 23, 24 , the ASH2L C-terminal SPRY (splA and ryanodine receptor) domain is sufficient to form a heterodimer with RBBP5 to stimulate the HKMT activity of MLL proteins (Fig. 1d , compare lanes 1 and 5). Three adjacent short motifs of RBBP5 were identified for the stimulation of MLL HKMT activity (residues 330-344, activation segment, AS), the interaction with ASH2L (residues 344-363, ASH2L-binding motif, ABM), and the association with WDR5 (residues 369-381, WDR5-binding motif, WBM) 24, 25 (Fig. 1a) . A preformed RBBP5 AS-ABM -ASH2L SPRY complex can stimulate MLL3 SET HKMT activity to levels of ~70% of full-length RBBP5-ASH2L (Fig. 1d, Fig. 3a) . Notably, we crystallized the M3RA complex both with and without the H3 peptide in one asymmetric unit (Extended Data Fig. 3b ).
In the M3RA complex, RBBP5 AS-ABM adopts an extended conformation that consists sequentially of two β-strands (activation segment) and a rigid coil (ABM), which respectively mediate the interactions with MLL3 SET and ASH2L SPRY (Fig. 2a) . The overall fold of MLL3 SET is similar to other SET-domain proteins, and shares the conserved features of N-and C-terminal regions (SET-N and SET-C), an insertion region (SET-I) and post-SET motifs 15, 26, 27 (Fig. 2b) . The active site residues of MLL3 SET , the conformation of the target lysine and an invariant water molecule, are almost identical to those of the active site of DIM-5 (ref. 28) , suggesting a catalytically active configuration of MLL3 SET (Fig. 2c) . The 'U'-shaped cofactor product AdoHcy binds into a well-defined surface pocket on MLL3 SET through an extensive network of highly conserved interactions as observed in other SET-domain structures ( Fig. 2d and Extended Data Fig. 3c, d ). The H3 substrate peptide sits in an opposite groove on the surface of MLL3 SET , and an intricate network of hydrogen bonds stabilizes the binding ( Fig. 2e and Extended Data Fig. 3e ). The unique geometry of the H3-binding groove specifically recognizes Thr3 H3 and Arg2 H3 , defining the substrate specificity of MLL3 SET (Extended Data Fig. 3f,  g ). Since all the H3-peptide-binding residues in MLL3 SET are highly conserved in other MLL proteins (Extended Data Fig. 4) , we conclude that all MLL proteins achieve the substrate specificity towards H3K4 through the same recognition mechanism as observed in the M3RA complex.
Interfaces in the M3RA complex
The structure of the M3RA complex reveals extensive interactions among ASH2L SPRY , RBBP5 AS-ABM and MLL3 SET . ASH2L SPRY recognizes RBBP5 ABM through extensive salt-bridge and hydrogenbonding interactions; the C-terminal portion of RBBP5 ABM adopts a coiled conformation sitting on two arginine residues (Arg343 and Arg367) at the centre of the basic pocket of ASH2L SPRY (Fig. 3a) . Mutations of ASH2L Arg343 and its interacting residues in RBBP5 ABM (Glu349 and Asp353) completely abrogated the RBBP5 ABM -ASH2L SPRY interaction (Extended Data Fig. 5a ) and impaired the HKMT activity of the MLL3 complex (Extended Data Fig. 5b ). The primary feature of the RBBP5 AS -MLL3 SET interaction is the intermolecular β-sheet interactions involving two strands of the L-shaped RBBP5 AS paring with β4 and an induced strand β7 immediately before helix αC of MLL3 SET (Fig. 3b) . Mutations of residues on this L-shaped motif partially decreased the HKMT activity of the MLL3 complex (Extended Data Fig. 5c ). In addition to these binary contacts, the side chain of the conserved Arg4806 of MLL3 SET sticks outside towards an acidic pocket formed by both RBBP5 ABM and ASH2L SPRY , forming five salt-bridge and hydrogen-bonding interactions with Glu347 RBBP5 , Tyr313 ASH2L and Gln354 ASH2L (Fig. 3c ). This extensive electrostatic network functions as an anchor point to fix the relative position of MLL3 SET to ASH2L SPRY , and is crucial for assembly of the MLL3-RBBP5-ASH2L complex.
Because the RBBP5 AS-ABM -ASH2L SPRY -interacting residues are highly conserved in MLL-family proteins (Extended Data Fig. 4) , we proposed that all MLL SET domains including MLL1 SET should interact with RBBP5-ASH2L through the same molecular surface as observed in the M3RA complex. In support of this idea, alanine substitutions of the conserved arginine residues in all MLL proteins, which do not affect the overall fold of MLL proteins (Extended Data Fig. 5d ), abolished the interaction between MLL SET and RBBP5-ASH2L (Fig. 3d) , and substantially decreased the HKMT activities of all MLL complexes (Fig. 3e) . Accordingly, mutations of the arginine-interacting residues on RBBP5 and ASH2L (RBBP5 Glu347 and ASH2L Gln354) also weakened the association of MLL SET with RBBP5-ASH2L, and reduced the HKMT activities of MLL complexes (Extended Data Fig. 5e, f) . Together, our data confirmed that the electrostatic network observed at the MLL3 SET -RBBP5-ASH2L interface is essential for the interaction between RBBP5-ASH2L and all MLL proteins. Interestingly, an inactivating mutation of the same key arginine residue in MLL4 (Arg5432Trp) that was identified in patients with non-Hodgkin lymphoma 9 also disrupted the interaction between MLL4 and RBBP5-ASH2L and abolished the HKMT activity (Fig. 3d,  e) , indicating that loss of a stable MLL4-RBBP5-ASH2L association leads to lymphomagenesis.
Difference between MLL1 and other MLL proteins
The structure of the M3RA complex revealed that subtle sequence differences in the RBBP5-ASH2L-binding region (residues 4804-4814 in MLL3) are probably responsible for the ability of RBBP5-ASH2L to distinguish MLL1 from other MLL proteins (Fig. 4a) . Most notably, the side chain of Val4809 in the SET-I motif of MLL3 SET fits snugly in a shallow pocket formed by both RBBP5 and MLL3 SET (Fig. 4b) , which can also accommodate the corresponding residues of MLL2, MLL4, SET1A and SET1B at the equivalent positions, but not for the bulky residue Gln3867 of MLL1 (Fig. 4a, b) . In addition, the side-chain methyl group of MLL3 SET Thr4803 is surrounded by three hydrophobic resides of RBBP5 AS (Leu339, Val343 and Tyr345) (Fig. 4c) . By contrast, a large hydrophilic residue Asn3861 at this position in MLL1 is incompatible with RBBP5 binding (Fig. 4c) . Thus, we proposed that two residues (Asn3861 and Gln3867) in MLL1 weaken the otherwise stable interaction between RBBP5-ASH2L and MLL1. Indeed, both MLL1-to-MLL2 (Asn3861Ile/Gln3867Leu) and MLL1-to-MLL3 (Asn3861Thr/Gln3867Val) double mutants of MLL1 re-gained stable interactions with RBBP5-ASH2L (Fig. 4d) , and WDR5 had no further stimulatory effect on the HKMT activities of these mutants (Fig. 4e) . Therefore, mutations of these two residues restore the strong RBBP5-ASH2L binding ability of MLL1 and thus bypass the requirement of WDR5 as the bridging molecule for the optimal HKMT activity of the MLL1 complex. This idea is further supported by the crystal structure of the / MLL1 SET N3861I Q3867L -RBBP5 AS-ABM -ASH2L SPRY complex (hereafter referred to as M1 M RA, in which 'M' denotes mutant) ( Fig. 4f and Extended Data Table 2 ). The structure of M1 M RA highly resembles that of M3RA, with an identical interface as the one between MLL3 SET and RBBP5-ASH2L (Fig. 4g) , strongly indicating that the RBBP5-ASH2L heterodimer interacts with and activates all MLL proteins through a conserved mechanism. Notably, the equivalent residues of MLL1 Asn3861 in SET1A (Gln1600) and SET1B (Gln1816) also have large hydrophilic side chains and therefore are not optimal for RBBP5-ASH2L binding (Fig. 4a) . This is consistent with the medium levels of interaction of SET1A and SET1B with RBBP5-ASH2L observed in the pull-down and fluorescence polarization assays (Extended Data  Fig. 2a, b) .
Activation mechanism of MLL complexes
Next we asked why MLL proteins by themselves are catalytically inactive, and how RBBP5-ASH2L stimulates their HKMT activities. One prevailing model suggests that the SET domain of MLL adopts an open conformation, and the interaction with regulatory factors induces MLL SET domain into a closed conformation 15 . To test this model, we crystallized apo MLL3 SET and determined its structure in complex with AdoHcy (Extended Data Fig. 6a) . Surprisingly, the apo structure of MLL3 SET was almost indistinguishable from the active conformation of MLL3 SET in the M3RA complex (Fig. 5a ). In addition, we also determined the crystal structure of MLL1 SET M ( / MLL1 SET N3861I Q3867L ), the SET-I motif of which exhibits an even more closed conformation than that in the M1 M RA complex ( Fig. 5b and Extended Data Fig. 6b ). Nevertheless, our data clearly showed that both MLL3 and MLL1 M by themselves are catalytically inactive (Fig. 4e and Extended Data Fig. 1 ). This apparent discrepancy between the low enzymatic activity and the closed conformation of MLL1 SET M or MLL3 SET led us to propose that, in the absence of RBBP5-ASH2L, MLL SET might be highly dynamic, and the configuration of MLL SET-I motif captured in the crystal structure is a snapshot of a spectrum of conformations of a mobile motif. In support of this idea, normal mode analysis revealed a highly dynamic motion of the SET-I motif in apo MLL1 SET M and MLL3 SET , which is substantially suppressed upon the association with RBBP5-ASH2L (Supplementary Videos 1-5) . To test this model experimentally, we use F-NMR spectrum of Phe4827, a key residue at the substrate-binding site in the SET-I motif, displayed two peaks at different chemical shifts, defining at least two different conformations or states with dynamic exchanges (Fig. 5c) . With titration of RBBP5-ASH2L, the 19 F-NMR spectrum showed prominent changes with conformational equilibrium towards a single Article reSeArcH active state, indicating that RBBP5-ASH2L reduced the flexibility of SET-I to lock it in an active state (Fig. 5c) . By contrast, Tyr4762 that is located in the SET-N motif exhibited no peak shift upon the addition of RBBP5-ASH2L (Fig. 5c) .
To provide further insight into this dynamic process, we carried out molecular dynamics simulation to investigate how RBBP5-ASH2L affects the structures of MLL3 SET and MLL1 SET M . Results showed that RBBP5-ASH2L reduces the root mean square fluctuation of helix αB and strand β7 of MLL3 SET substantially (Fig. 5d ). This coincides with our observation that the most variable element in apo MLL SET is the αB helix, illustrated by the superimposition of four apo MLL SET structures (Extended Data Fig. 6c ). Furthermore, a flexible loop in apo MLL3 SET (L 6C ) is induced to form strand β7 by pairing with strand β1 of RBBP5 AS (Fig. 5e) . Other than the structural variation of individual residues, molecular dynamics simulation also clearly showed that the cross-correlation within the SET-I motif was greatly enhanced upon RBBP5-ASH2L association ( Fig. 5f and Extended Data Fig. 6d-f) . The reduced flexibility of the SET-I motif may help cofactor binding and Article reSeArcH substrate recognition. Indeed, isothermal titration calorimetry (ITC) analysis showed that the binding affinities of cofactor to MLL3 SET and MLL1 SET M are markedly increased in the presence of RBBP5-ASH2L (Extended Data Fig. 7a, b) . Furthermore, the association with RBBP5-ASH2L also facilitates MLL3 binding with the H3 substrate peptide (Extended Data Fig. 7c) . Notably, Phe336 at the beginning of β1 in RBBP5 AS stacks together with the side chains of MLL3 SET /MLL1 SET M Arg4845/Arg3903, Tyr4846/Phe3904 and Tyr4825/Tyr3883, and the latter makes a direct hydrogen-bonding interaction with AdoHcy (Fig. 5e ). Molecular dynamics simulation revealed an obvious stabilizing effect of RBBP5-ASH2L on this network of interactions, which could explain the enhanced cofactor-binding ability for the M3RA complex (Extended Data Fig. 7d ). Quantum mechanics/molecular mechanics (QM/MM) investigations further indicated that the presence of RBBP5-ASH2L facilitated the methyl transfer process from the cofactor AdoMet to the target lysine by lowering the energy barrier (Extended Data Fig. 7e ). Taken together, we conclude that the RBBP5-ASH2L-induced conformational constraints on the SET-I motif help to stabilize MLL SET in a conformation competent for cofactor binding and substrate recognition.
Structural comparison of the M3RA complex structures with and without the H3 peptide revealed a role of the substrate peptide in further stabilizing the active conformation of MLL3 SET , which has been observed in other SET-domain methyltranferases 28 . After H3 binding, a marked local structural rearrangement occurs to loop L B5 between helix αB and strand β5 in the SET-I motif, leading to the completion of a narrow hydrophobic channel that orients the H3 Lys4 side chain for catalysis (Fig. 5g) . Remarkably, the side chain of MLL3 Val4824 shifts ~4.1 Å and rotates ~50° relative to its position in the H3-peptide-free structure, enclosing the target lysine access channel (Extended Data Fig. 7f) . Collectively, our studies suggest a novel two-step mechanism for MLL SET activation: interaction with the RBBP5-ASH2L heterodimer reduces the inherent flexibility of MLL SET and favours formation of a catalytically competent conformation; and then H3 substrate binding induces a local conformational change in the SET-I motif of MLL SET to achieve the fully active configuration that facilitates the methyl transfer process (Fig. 5h) .
Implications for other methyltransferases
Structural comparison of the M1 M RA and M3RA complexes with a large group of SET domain proteins reveals a striking similarity with other intrinsic active methyltransferases. In all SUV39-and SET2-family proteins, a short fragment amino-terminal to the pre-SET region (referred to as the activation segment) interacts with the SET-I motif in the same manner as RBBP5 AS binding to MLL3 SET (Extended Data Fig. 8a, b) . Deletion of this activation segment from DIM-5 did not affect the overall fold of the protein but completely abrogated the HKMT activity of DIM-5, underscoring the importance of this segment in DIM-5 activity regulation (Extended Data Fig. 8c, d) . Such an activation segment is also found in the EZH2 complex structure 29 , further supporting a conserved activation mechanism for a subset of SET-domain-containing methyltransferases.
In summary, the present structural, biochemical and computational analyses provide new insights into the assembly and regulation mechanism of MLL family complexes. Our results suggest that a minimized RBBP5-ASH2L heterodimer is the structural unit to interact with and activate all MLL family histone methyltransferases. By contrast, WDR5 is not directly involved in the enzymatic stimulation of MLL complexes. WDR5 may serve as a recruitment module or crosstalk mediator to regulate H3K4 methylation in vivo [30] [31] [32] [33] [34] .
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